Journal
CURRENT DIABETES REPORTS
Volume 9, Issue 3, Pages 200-207Publisher
CURRENT MEDICINE GROUP
DOI: 10.1007/s11892-009-0033-6
Keywords
-
Categories
Funding
- Burroughs Wellcome Fund
- American Diabetes Association
- Veterans Affairs Medical Research Fund
Ask authors/readers for more resources
Early interventions to prevent type 2 diabetes mellitus (T2DM) demand a better understanding of its underlying mechanisms. Nonobese healthy subjects with a strong family history of T2DM (FH+ subjects) hold a key to this end by allowing the study of the disease before the development of confounding factors, such as obesity or hyperglycemia. In this article, we share our experience over the past decade in studying FH+ subjects and how lipotoxicity alters glucose metabolism in such individuals, in particular pancreatic beta-cell function. FH+ subjects have no obvious clinical abnormalities, but when carefully studied, reveal severe hepatic/muscle/adipose tissue insulin resistance and subtle defects in beta-cell function. In most subjects, metabolic adaption allows freedom from diabetes for decades. However, the obesity epidemic is drastically changing this. Given the unique susceptibility of pancreatic beta cells to free fatty acids in FH+ subjects, interventions that protect against obesity-induced lipotoxicity may hold the greatest promise for preventing T2DM in genetically predisposed individuals.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available